Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19Original Article Published on 2020-01-012022-10-31 Journal: Gastroenterology and Hepatology From Bed to Bench [Category] COVID-19, [키워드] 6LU7 Algorithm anti-CoV drug antiprotease applied approach approved binding binding site calculated Cobicistat compounds conducted conformation conformations COVID-19 demonstrated determine docking docking scores docking study DOS drug drugs Effectiveness exhibited FDA FDA approved drug In-vitro inhibitor Interaction Ligand main protease molecular docking molecular target MPro Mpro/6LU7 potential therapeutic agents protease Protease inhibitor Protein Repository Result RMSD screened selected selected drug Simeprevir Spread Temoporfin the disease Treatment Viral antiprotease drugs was obtained was performed with COVID-19 PMC 바로가기 [Article Type] Original Article